Cooperation between HMGA1, PDX-1 and MafA is essential for glucose-induced insulin transcription in pancreatic beta cells

Frontiers in Endocrinology

Volumn 5, Issue DEC, 2014, Pages

  Arcidiacono, Biagio ^a   Iiritano, Stefania ^a   Chiefari, Eusebio ^a   Brunetti, Francesco S ^a   Gu, Guoqiang ^b   Foti, Daniela ^a   Brunetti, Antonio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Diabetes; HMGA1; Insulin gene; MafA; PDX 1; Transcription; cells

Indexed keywords

GLUCOSE; GLUTATHIONE TRANSFERASE; HIGH MOBILITY GROUP AT HOOK 1 PROTEIN; INSULIN RECEPTOR; PEPTIDES AND PROTEINS; PROTEIN V MAF; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PDX 1; UNCLASSIFIED DRUG;

ANIMAL CELL; BINDING ASSAY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONTROL; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN INTERACTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ANALYSIS; TRANSIENT TRANSFECTION; UPREGULATION; WESTERN BLOTTING;

EID: 84920122824     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00237     Document Type: Review

References (60)

1. Brunetti A, Chiefar E, Foti D. Recent advances in the molecular genetics of type 2 diabetes mellitus. World J Diabetes (2014) 5(2):128-40
2. Brunetti A, Chiefari E, Foti D. Perspectives on the contribution of genetics to the pathogenesis of type 2 diabetes mellitus. Recenti Prog Med (2011) 102(12):468-75
3. Fu Z, Gilbert ER, Liu D. Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes. Curr Diabetes Rev (2013) 9(1):25-53
4. Vander Mierde D, Scheuner D, Quintens R, Patel R, Song B, Tsukamoto K, et al. Glucose activates a protein phosphatase-1-mediated signaling pathway to enhance overall translation in pancreatic beta-cells. Endocrinology (2007) 148(2):609-17
5. Sharma A, Stein R. Glucose-induced transcription of the insulin gene is mediated by factors required for beta-cell-type-specific expression. Mol Cell Biol (1994) 14(2):871-9
6. German M, Ashcroft S, Docherty K, Edlund H, Edlund T, Goodison S, et al. The insulin gene promoter. A simplified nomenclature. Diabetes (1995) 44(8):1002-4
7. Hay CW, Docherty K. Comparative analysis of insulin gene promoters: implications for diabetes research. Diabetes (2006) 55(12):3201-13
8. Walker MD, Edlund T, Boulet AM, Rutter WJ. Cell-specific expression controlled by the 5'-flanking region of insulin and chymotrypsin genes. Nature (1983) 306(5943):557-61
9. Melloul D, Ben-Neriah Y, Cerasi E. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc Natl Acad Sci USA (1993) 90(9):3865-9
10. Melloul D, Marshak S, Cerasi E. Regulation of insulin gene transcription. Diabetologia (2002) 45(3):309-26
11. German MS, Wang J. The insulin gene contains multiple transcriptional elements that respond to glucose. Mol Cell Biol (1994) 14(6):4067-75
12. Petersen HV, Serup P, Leonard J, Michelsen BK, Madsen OD. Transcriptional regulation of the human insulin gene is dependent on the homeodomain protein STF1/IPF1 acting through the CT boxes. Proc Natl Acad Sci USA (1994) 91(22):10465-9
13. Sander M, German MS. The beta cell transcription factors and development of the pancreas. J Mol Med (1997) 75(5):327-40
14. Ohneda K, Mirmira RG, Wang J, Johnson JD, German MS. The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. Mol Cell Biol (2000) 20(3):900-11
15. Boam DS, Docherty K. A tissue-specific nuclear factor binds to multiple sites in the human insulin-gene enhancer. Biochem J (1989) 264(1):233-9
16. Leonard J, Peers B, Johnson T, Ferreri K, Lee S, Montminy MR. Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol (1993) 7(10):1275-83
17. Ohlsson H, Karlsson K, Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J (1993) 12(11):4251-9
18. Miller CP, McGehee RE Jr, Habener JF. IDX-1: A new homeodomain transcription factor expressed in rat pancreatic islets and duodenum that transactivates the somatostatin gene. EMBO J (1994) 13(5):1145-56
19. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature (1994) 371(6498):606-9
20. Marshak S, Totary H, Cerasi E, Melloul D. Purification of the beta-cell glucose-sensitive factor that transactivates the insulin gene differentially in normal and transformed islet cells. Proc Natl Acad Sci USA (1996) 93(26):15057-62
21. McKinnon CM, Docherty K. Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function. Diabetologia (2001) 44(10):1203-14
22. Kaneto H, Miyatsuka T, Kawamori D, Yamamoto K, Kato K, Shiraiwa T, et al. PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function. Endocr J (2008) 55(2):235-52
23. Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H. Beta-cell specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev (1998) 12(12):1763-8
24. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet (1997) 17(2):138-9
25. Macfarlane WM, Frayling TM, Ellard S, Evans JC, Allen LI, Bulman MP, et al. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest (1999) 104(9):R33-9
26. Olbrot M, Rud J, Moss LG, Sharma A. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci USA (2002) 99(10):6737-42
27. Kataoka K, Shioda S, Ando K, Sakagami K, Handa H, Yasuda K. Differentially expressed Maf family transcription factors, c-Maf and MafA, activate glucagon and insulin gene expression in pancreatic islet alpha- and beta-cells. J Mol Endocrinol (2004) 32(1):9-20
28. Matsuoka TA, Zhao L, Artner I, Jarrett HW, Friedman D, Means A, et al. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol Cell Biol (2003) 23(17):6049-62
29. Kaneto H, Matsuoka TA, Kawashima S, Yamamoto K, Kato K, Miyatsuka T, et al. Role of MafA in pancreatic beta-cells. Adv Drug Deliv Rev (2009) 61(7-8):489-96
30. Hang Y, Stein R. MafA and MafB activity in pancreatic β cells. Trends Endocrinol Metab (2011) 22(9):364-73
31. Zhao X, Mohan R, Özcan S, Tang X. MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic β-cells. J Biol Chem (2012) 287(37):31155-64
32. Guo S, Dai C, Guo M, Taylor B, Harmon JS, Sander M, et al. Inactivation of specific β cell transcription factors in type 2 diabetes. J Clin Invest (2013) 123(8):3305-16
33. Artner I, Hang Y, Mazur M, Yamamoto T, Guo M, Lindner J, et al. MafA and MafB regulate genes critical to beta-cells in a unique temporal manner. Diabetes (2010) 59(10):2530-9
34. Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol (1996) 54:35-100
35. Munshi N, Agalioti T, Lomvardas S, Merika M, Chen G, Thanos D. Coordination of a transcriptional switch by HMGI(Y) acetylation Science (2001) 293(5532):1133-6
36. Foti D, Iuliano R, Chiefari E, Brunetti A. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol Cell Biol (2003) 23(8):2720-32
37. Cleynen I, Van de Ven WJ. The HMGA proteins: a myriad of functions. Int J Oncol (2008) 32(2):289-305
38. Foti D, Chiefari E, Fedele M, Iuliano R, Brunetti L, Paonessa F, et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med (2005) 11(7):765-73
39. Brunetti A, Manfioletti G, Chiefari E, Goldfine ID, Foti D. Transcriptional regulation of the insulin receptor by the high mobility group protein HMGI(Y). FASEB J (2001) 15(2):492-500
40. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, et al. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development (1996) 122(3):983-95
41. Brunetti A, Foti D, Goldfine ID. Identification of unique nuclear regulatory proteins for the insulin receptor gene, which appear during myocyte and adipocyte differentiation. J Clin Invest (1993) 92(3):1288-95
42. Brunetti A, Brunetti L, Foti D, Accili D, Goldfine ID. Human diabetes associated with defects in regulatory proteins for the insulin receptor gene. J Clin Invest (1996) 97(1):258-62
43. Paonessa F, Foti D, Costa V, Chiefari E, Brunetti G, Leone F, et al. Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer. Cancer Res (2006) 66(10):5085-93
44. Chiefari E, Paonessa F, Iiritano S, Le Pera I, Palmieri D, Brunetti G, et al. The cAMP502 HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 7:24
45. Wang S, Yan J, Anderson DA, Xu Y, Kanal MC, Cao Z, Wright CV, et al. Neurog3 gene dosage regulates allocation of endocrine and exocrine cell fates in the developing mouse pancreas. Dev Biol (2010) 339(1):26-37
46. Massaad-Massade L, Navarro S, Krummrei U, Reeves R, Beaune P, Barouki R. HMGA1 enhances the transcriptional activity and binding of the estrogen receptor to its responsive element. Biochemistry (2002) 41(8):2760-8
47. Andrali SS, Sampley ML, Vanderford NL, Ozcan S. Glucose regulation of insulin gene expression in pancreatic beta-cells. Biochem J (2008) 415(1):1-10
48. Vanderford NL. Regulation of β-cell-specific and glucose-dependent MafA expression. Islets (2011) 3(1):35-7
49. Unger RH. Reinventing type 2 diabetes: pathogenesis, treatment, and prevention. JAMA (2008) 299(10):1185-7
50. Milos PM, Zaret KS. A ubiquitous factor is required for C/EBP-related proteins to form stable transcription complexes on an albumin promoter segment in vitro. Genes Dev (1992) 6(6):991-1004
51. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerström C, Andersson A. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci USA (1994) 91(20):9253-6
52. Kim SK, Hebrok M. Intercellular signals regulating pancreas development and function. Genes Dev (2001) 15(2):111-27
53. Semple RK. From bending DNA to diabetes: the curious case of HMGA1. J Biol (2009) 8(7):64
54. Chiefari E, Iiritano S, Paonessa F, Le Pera I, Arcidiacono B, Filocamo M, et al. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes. Nat Commun (2010) 1:40
55. Chiefari E, Tanyolaç S, Paonessa F, Pullinger CR, Capula C, Iiritano S, et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA (2011) 305(9):903-12
56. Iiritano S, Chiefari E, Ventura V, Arcidiacono B, Possidente K, Nocera A, et al. The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake. Mol Endocrinol (2012) 26(9):1578-89
57. Liu L, Ding H, Wang HR, Xu YJ, Cui GL, Wang PH, et al. Polymorphism of HMGA1 is associated with increased risk of type 2 diabetes among Chinese individuals. Diabetologia (2012) 55(6):1685-8
58. Chiefari E, Nevolo MT, Arcidiacono B, Maurizio E, Nocera A, Iiritano S, et al. HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway. Sci Rep (2012) 2:251
59. Chiefari E, Tanyolaç S, Iiritano S, Sciacqua A, Capula C, Arcidiacono B, et al. A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci Rep (2013) 3:1491
60. Pullinger CR, Goldfine ID, Tanyolaç S, Movsesyan I, Faynboym M, Durlach V, et al. Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population. Metab Syndr Relat Disord (2014) 12(1):25-30